Aenne-Dorothea Liebing

Aenne-Dorothea Liebing

Auto-generated profile, based on publicly available information

Aenne-Dorothea Liebing

Rudolf Schönheimer Institute of Biochemistry, Faculty of Medicine, Leipzig University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in Nature
Verified
Journal Article
Open access
PDF file
RTRomy Thomas
Romy Thomas
PJPauline S. Jacoby
Pauline S. Jacoby
CFChiara De Faveri
Chiara De Faveri
CDCécile Derieux
Cécile Derieux
ALAenne-Dorothea Liebing
Aenne-Dorothea Liebing
ABAndreas Bock
Andreas Bock
G-protein-coupled receptors (GPCRs) are key mediators of cell communication and represent the most important class of drug targets 1,2 . Biophysical studies with purified GPCRs in vitro have suggested that they exist in an equilibrium of distinct inactive and active states, which is modulated by ligands in an efficacy-dependent manner 3–11 . However, how efficacy is encoded and whether multiple receptor states occur in living cells remain unclear. Here we use genetic code expansion 12 and bioorthogonal labelling 13–16 to generate a panel of fluorescence-based biosensors for a prototypical GPCR, the M 2 muscarinic acetylcholine receptor (M 2 R). These biosensors enable real-time monitoring of agonist-promoted conformational changes across the receptor’s extracellular surface in intact cells. We demonstrate that different agonists produce equilibria of at least four distinct active states of the G-protein-bound M 2 R, each with a different ability to activate G proteins. The formation of these M 2 R–G-protein complexes occurs over 0.2–5 s along trajectories that involve both common and ligand-specific conformational changes and appear to determine G-protein selectivity. These observations reveal the molecular nature of ligand efficacy in intact cells. Selectively exploiting such different GPCR activation trajectories and conformational equilibria may open new avenues for GPCR drug discovery.

10 June 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CMCheng Ma
Cheng Ma
ALAenne-Dorothea Liebing
Aenne-Dorothea Liebing
GKGunnar Kleinau
Gunnar Kleinau
AKAntje Kamprad
Antje Kamprad
LCLouisa Calabrese
Louisa Calabrese
LALeif Andersson
Leif Andersson
The domestic chicken exhibits extraordinarily high plumage diversity in sharp contrast to the uniform plumage phenotype in its wild ancestor, the red junglefowl. The melanocortin-1 receptor ( MC1R ) locus is the most variable pigmentation locus in domestic chicken. Here we have analyzed whole-genome sequence data from 10,026 birds, including red junglefowls and 393 populations of domestic chicken. We document ultrarapid evolution of 18 MC1R alleles, due to the accumulation of 9 missense mutations combined with reshuffling of sequence variants within the single MC1R exon. The lack of linkage disequilibrium at the MC1R locus strongly suggests that this combinatorial allele diversity is generated by interallelic gene conversion, possibly promoted by its high guanine–cytosine content. Functional analyses of MC1R variants expressed in transfected cells, using second-messenger and bioluminescence resonance energy transfer assays together with homology modeling, demonstrate that most missense mutations have significant effects on MC1R signaling and include both activating and inhibitory changes. One common MC1R allele differs by as many as three functionally relevant missense mutations from the most closely related wild-type allele, and its phenotype reflects their combined effects. Genome-wide analyses further show that MC1R acts as a modifier of dominant white and recessive white phenotypes caused by mutations in premelanosome protein and tyrosinase , respectively. In both cases, MC1R alleles promote a pure white phenotype, either by enhancing eumelanin pigmentation (dominant white) or inhibiting eumelanin pigmentation (recessive white).

23 September 2025 in Research Square
Verified
Preprint
Open access
PDF file
Sorin TunaruSorin Tunaru
Sorin Tunaru
SASorina Anghel
Sorina Anghel
RBRodica Badea
Rodica Badea
CTCosmin Trif
Cosmin Trif
TSTeodora Stratulat
Teodora Stratulat
JHJulien Hanson
Julien Hanson
G protein-coupled receptors 27 and 173 (GPR27 and GPR173) are part of the "Super Conserved Receptors Expressed in Brain" (SREB) family, alongside GPR85. While the endogenous ligands and functions of SREB receptors are still unknown, GPR27 has been implicated in insulin secretion and tumorigenesis, whereas GPR173 has been proposed to be a receptor mediating biological effects of phoenixin-20 amide. Here, we show that substituting GPR27’s C-terminal domain with that of the β1 adrenergic receptor (β1AR) yields a chimera with β1AR-like ligand selectivity and cellular functions. Interestingly, stimulation of GPR27 with isoproterenol and adrenergic ligands inhibited epidermal growth factor (EGF)-induced serum-responsive element (SRE) activation, independently of G proteins and β-arrestins, and induced GPR27 internalization.Surprisingly, GPR173 responded exclusively to noradrenaline, showing both inhibition of EGF-induced SRE activity and receptor internalisation, whereas GPR85 remained unresponsive to the tested adrenergic ligands. Taken together, these intriguing findings suggest that GPR27 and GPR173 respond to adrenergic ligands to transinhibit EGFR through a unique and atypical signaling mechanism, previously undescribed for any known GPCR. Moreover, we provide the first evidence of ligand-induced functional transinhibition of a receptor tyrosine kinase, such as EGFR, by a GPCR, opening new research lines with translational potential.